These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 22458933

  • 1. Methylation profiling of Epstein-Barr virus immediate-early gene promoters, BZLF1 and BRLF1 in tumors of epithelial, NK- and B-cell origins.
    Li L, Su X, Choi GC, Cao Y, Ambinder RF, Tao Q.
    BMC Cancer; 2012 Mar 29; 12():125. PubMed ID: 22458933
    [Abstract] [Full Text] [Related]

  • 2. Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication.
    Wille CK, Nawandar DM, Panfil AR, Ko MM, Hagemeier SR, Kenney SC.
    J Virol; 2013 Jan 29; 87(2):935-50. PubMed ID: 23135711
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1.
    Jung YJ, Choi H, Kim H, Lee SK.
    J Virol; 2014 Aug 29; 88(16):9027-37. PubMed ID: 24899173
    [Abstract] [Full Text] [Related]

  • 4. Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.
    Reusch JA, Nawandar DM, Wright KL, Kenney SC, Mertz JE.
    J Virol; 2015 Feb 29; 89(3):1731-43. PubMed ID: 25410866
    [Abstract] [Full Text] [Related]

  • 5. Use of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors.
    Feng WH, Westphal E, Mauser A, Raab-Traub N, Gulley ML, Busson P, Kenney SC.
    J Virol; 2002 Nov 29; 76(21):10951-9. PubMed ID: 12368338
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. 5-hydroxymethylation of the EBV genome regulates the latent to lytic switch.
    Wille CK, Nawandar DM, Henning AN, Ma S, Oetting KM, Lee D, Lambert P, Johannsen EC, Kenney SC.
    Proc Natl Acad Sci U S A; 2015 Dec 29; 112(52):E7257-65. PubMed ID: 26663912
    [Abstract] [Full Text] [Related]

  • 8. Cellular immediate-early gene expression occurs kinetically upstream of Epstein-Barr virus bzlf1 and brlf1 following cross-linking of the B cell antigen receptor in the Akata Burkitt lymphoma cell line.
    Ye J, Gradoville L, Miller G.
    J Virol; 2010 Dec 29; 84(23):12405-18. PubMed ID: 20861250
    [Abstract] [Full Text] [Related]

  • 9. Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus's natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter.
    Kraus RJ, Yu X, Cordes BA, Sathiamoorthi S, Iempridee T, Nawandar DM, Ma S, Romero-Masters JC, McChesney KG, Lin Z, Makielski KR, Lee DL, Lambert PF, Johannsen EC, Kenney SC, Mertz JE.
    PLoS Pathog; 2017 Jun 29; 13(6):e1006404. PubMed ID: 28617871
    [Abstract] [Full Text] [Related]

  • 10. Methylation-dependent binding of the epstein-barr virus BZLF1 protein to viral promoters.
    Dickerson SJ, Xing Y, Robinson AR, Seaman WT, Gruffat H, Kenney SC.
    PLoS Pathog; 2009 Mar 29; 5(3):e1000356. PubMed ID: 19325883
    [Abstract] [Full Text] [Related]

  • 11. Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virus-infected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors.
    Countryman JK, Gradoville L, Miller G.
    J Virol; 2008 May 29; 82(10):4706-19. PubMed ID: 18337569
    [Abstract] [Full Text] [Related]

  • 12. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome.
    Le Roux F, Sergeant A, Corbo L.
    J Gen Virol; 1996 Mar 29; 77 ( Pt 3)():501-9. PubMed ID: 8601788
    [Abstract] [Full Text] [Related]

  • 13. Reactivation of Epstein-Barr Virus by HIF-1α Requires p53.
    Kraus RJ, Cordes BA, Sathiamoorthi S, Patel P, Yuan X, Iempridee T, Yu X, Lee DL, Lambert PF, Mertz JE.
    J Virol; 2020 Aug 31; 94(18):. PubMed ID: 32641480
    [Abstract] [Full Text] [Related]

  • 14. Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo.
    Westphal EM, Mauser A, Swenson J, Davis MG, Talarico CL, Kenney SC.
    Cancer Res; 1999 Apr 01; 59(7):1485-91. PubMed ID: 10197618
    [Abstract] [Full Text] [Related]

  • 15. BZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186.
    Bhende PM, Seaman WT, Delecluse HJ, Kenney SC.
    J Virol; 2005 Jun 01; 79(12):7338-48. PubMed ID: 15919888
    [Abstract] [Full Text] [Related]

  • 16. BZLF1 governs CpG-methylated chromatin of Epstein-Barr Virus reversing epigenetic repression.
    Woellmer A, Arteaga-Salas JM, Hammerschmidt W.
    PLoS Pathog; 2012 Sep 01; 8(9):e1002902. PubMed ID: 22969425
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The BRRF1 early gene of Epstein-Barr virus encodes a transcription factor that enhances induction of lytic infection by BRLF1.
    Hong GK, Delecluse HJ, Gruffat H, Morrison TE, Feng WH, Sergeant A, Kenney SC.
    J Virol; 2004 May 01; 78(10):4983-92. PubMed ID: 15113878
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Contribution of myocyte enhancer factor 2 family transcription factors to BZLF1 expression in Epstein-Barr virus reactivation from latency.
    Murata T, Narita Y, Sugimoto A, Kawashima D, Kanda T, Tsurumi T.
    J Virol; 2013 Sep 01; 87(18):10148-62. PubMed ID: 23843637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.